Search

Announcing Bank of America as Coyote Ventures' latest partner

Updated: Nov 21

To date, Bank of America is the largest institutional investor in our Fund I and follows previous investments from The Case for Her and Tripple Family Office.

Bank of America as Coyote Ventures latest partner
Illustration by Gabriella Turrisi / Axios

Jess, our General Partner, founded Coyote Ventures in 2021 when she recognized how gender inequality in venture capital led to a lack in funding for female-specific solutions. Within a year, we have now expanded our all-female deal team and our advisor network of doctors, scientists, and healthtech executives. Together, our venture partners, investment committee, and fellows bring decades of experience from digital health, consumer products, medicine, and tech. Further, our board of advisors bring expertise in several verticals of healthcare including medtech, digital health, biotech, clinical care, and reproductive health. Our strong deal flow is a direct reflection of our all-star team.

To quote Jess, “According to data from Pitchbook, of the $105B invested in health and wellness startups in the US in 2021, only 2% was invested in solutions that serve women. This is a massively underserved market that we estimate is valued at over $1T globally. We are beyond excited that Bank of America has committed as a partner in driving more early-stage funding.”


We Invested in Portfolio Companies who cover various verticals within Health and Wellness


Coyote is proud that all CEOs in our portfolio companies are female, with many of the co-founders identifying as BIPOC and/or LGBTQ+, directly reflecting our mission to close the gender inequality gap. Our portfolio companies cover various verticals within health and wellness including but not limited to hormonal health, maternal health, sexual wellness, menstruation, and cancer diagnostics. Flex Company creates innovative period products that are better for menstrual health and the environment. Gabbi was founded with a mission to empower and inform women of their risk for breast cancer. Hera Biotech is developing the world’s first non-surgical test capable of both staging and diagnosing endometriosis. Maude is redefining sexual essentials for modern consumers while O.School is developing a sexual wellness platform that aims to serve as the trusted source for sexual education. Wile is tackling issues faced by women in their 40+ by creating hormonal wellness supplements for those who are past their child-bearing age. Malama Health, on the other hand, is focused on addressing high risk prenatal conditions for those who are carrying children through their management and care platform, starting with gestational diabetes. For more information on why we invested in each of the respective companies above, see here.

Gioia McCarthy, President at Bank of America San Francisco-East Bay, comments: “The health crisis has impacted all of us but disproportionately minority women. At Bank of America, we want to facilitate more equitable opportunities for underrepresented entrepreneurs and address the challenges that women entrepreneurs face, especially when it comes to securing funds to start or grow their business.”

The news broke exclusively on Axios, and was also featured by FemTech Insider, Yahoo News, and Private Equity Wire. The full release can be found on Businesswire.

34 views0 comments

Recent Posts

See All